Therapeutics · Defense · AI

Mission Critical
Medical Enhancement

Mission Critical
Medical Enhancements

Mission Critical
Medical Enhancements

Infrastructure for warfighter performance

Schedule Intro

Schedule Intro

Team

We develop U.S. government-validated dual-use therapeutics, with expertise gained at Harvard and the USAMRICD; under YC-grade advisors guidance

We develop U.S. government-validated dual-use therapeutics, with expertise gained at Harvard and the USAMRICD; under YC-grade advisors guidance

Drug Developer

Harvard trained scientist and two time founder, specialized in high-throughput drug development and science translation. Passionate about AI and robotics automation.

Fabian Mulder

Co-Founder & CEO

Drug Developer

Harvard trained scientist and two time founder, specialised in high-throughput drug development and science translation. Passionate about AI and robotics.

Eric Herrera

Advisor & Scientist

Dual-use Expert

Lieutenant Herrera conducted research at the U.S. Army Medical Research Institute of Chemical Defense and explored problem driven neurochemical systems. Connected to DoD.

Business Strategist

Seasoned entrepreneur in the development of novel chemicals. Experienced in scaling early-stage start-ups through Y-Combinator. Guiding Legion to move quickly and tactfully.

  • 19 - 23Jan
    Add

    World Economic Forum 2026

    Monday, January 19, 2026 • 9:00 AM - 7:00 PM
    Davos, Switzerland
  • 23-25Mar
    Add

    Bio-Europe Spring

    Monday, March 23, 2026 • 9:00 AM - 7:00 PM
    Lisbon Convention Center
  • 17-20Jun
    Add

    VivaTech 2026 | Viva Technology

    Monday, Wednesday 17, 2026 • 9:00 AM - 7:00 PM
    Paris, France
19 - 23Jan
Add

World Economic Forum 2026

January 19, 2026 • 9:00 AM - 7:00 PM
Davos, Switzerland